Hypersensitivity Type I, II, III and IV- Summary in table form
By
MN Editors
•
Hypersensitivity (also known as hypersensitivity response or intolerance) is a term used to describe undesirable reactions that are caused by the immune system, which includes autoimmunity and allergies. These are typically called an overreaction of the immune system, and these reactions can be harmful and uncomfortable. It is an immunologic term , and should not be misinterpreted as a psychiatric term of being hypersensitive, which refers that a person is hypersensitive to physical (ie sounds, touch light, sound, etc.) or emotional stimuli. However, there is a link between the two , studies have demonstrated that with ADHD (a mental disorders) tend to experience hypersensitivity reactions, such as asthma, allergies, or eczema and more than people who don’t have ADHD.
Different kinds of hypersensitivity reactions
The hypersensitivity reaction can be divided into 4 different types.
Type I: IgE mediated immediate reaction
Type II: The antibody-mediated Cytotoxic Reaction (IgG or IgM antibodies)
Type III: Complex-mediated immune immune reaction
Type IV: cell-mediated delayed hypersensitivity reaction that is delayed
The three first types are considered to be immediate hypersensitivity reactions since they happen after 24 hours. The fourth kind is known as delayed hypersensitivity reactions because it typically occurs for longer than 12 hours after being exposed to an allergen with the maximum time of reaction of between 72 and 48 hours.
Alternative Name
Type I
Type II
Type III
Type IV
Hypersensitivity to allergens
Hypersensitivity to cytotoxic chemicals
Complex hypersensitivity to immune system
Hypersensitivity caused by cells/ delayed kind of hypersensitivity
Principle
Type I
Type II
Type III
Type IV
Antibody-mediated degranulation and granulocyte degranulation leading to the death of cells.
The destruction by antibodies of cells that are healthy.
Complex-mediated destruction of cells by antigens.
T lymphocytes are responsible for elimination of the cells.
Primary Mediator
Type I
Type II
Type III
Type IV
IgE
IgG/IgM
IgG/IgM
Certain subsets of helper CD4+ T cells or T cells that are CD8+.
Other components that act as mediators
Type I
Type II
Type III
Type IV
Mast cell, Basophils and histamine, among other drugs
After 24 hours, but generally between 48 and 72 hours after contact.
Antigen
Type I
Type II
Type III
Type IV
Free to circulate (Soluble)
Fixed on cells
Free to circulate ( Soluble)
Cell-bound or soluble
Antigen origin
Type I
Type II
Type III
Type IV
Exogenous
Exogenous or endogenous
Endogenous or exogenous
Endogenous or exogenous
Antibody
Type I
Type II
Type III
Type IV
Retained on the mast cell and in basophils.
Free circulation
Free to circulate
Non-applicable
Mechanism
Type I
Type II
Type III
Type IV
Allergen-specific IgE antibodies attach to mast cells through the Fc receptor. When the allergen of interest is bound to the IgE and cross-links with IgE results in the disgranulation in mast cells.
IgG and IgM antibody can bind to a cell-specific antigen which triggers complement activation and cell destruction. IgG can also play a role in ADCC by macrophages, natural killer cells and neutrophils.
Antigen-antibody complexes accumulate in tissues. Complement activation releases inflammation mediators and also recruits neutrophils. Inflammatory enzymes released by neutrophils harm tissues.
Th2 cells release cytokines that activate macrophages as well as T cells that are cytotoxic.
Compliment activation
Type I
Type II
Type III
Type IV
No
Yes
Yes
No
Appearance
Type I
Type II
Type III
Type IV
Weal & flare
Lysis and necrosis
Erythema and the edema
Erythema and induration
Transfer using serum
Type I
Type II
Type III
Type IV
Serum can be used to transfer blood.
Transfer of funds via passive
Transfer via passive
It is not possible to transfer via serum, but it is it is possible to transfer T cells
The tuberculin reaction, the Granuloma development, Allergic contact skin rashes Type-1 diabetes
We hope you've enjoyed reading our latest blog article! We're thrilled to see the positive response it's been
receiving so far. We understand that sometimes, after going through an interesting piece of content, you might
have questions or want to delve deeper into the topic.
To facilitate meaningful discussions and encourage knowledge sharing, we've set up a dedicated QNA Forum page
related to this specific article. If you have any questions, comments, or thoughts you'd like to share, we invite
you to visit the QNA Forum.
Feel free to ask your questions or participate in ongoing discussions. Our team of experts, as well as fellow
readers, will be active on the forum to engage with you and provide insightful answers.
Remember, sharing your thoughts not only helps you gain a deeper understanding but also contributes to the
community's growth and learning. We look forward to hearing from you and fostering an enriching discussion.
Thank you for being a part of our journey!
